Subject: Week in Review: PSID BICX PZOO News Moves Stocks in the Right Direction

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
Week in Review: PSID BICX PZOO News Moves Stocks in the Right Direction
Hot Stock to WatchHot Stock to Watch

Company: PositiveID Corporation (OTCQB: PSID)

End of Day:

Price: 0.0266

Change (%): - 0.0004 (1.48)

Volume: 2,768,799
PSID Chart

PositiveID Achieves Firefly Dx Development Milestone With the Production of Injection-Molded PCR Chips

Injection-Molding Allows the Company to Inexpensively Produce Large Quantities of Its PCR Chip for the Firefly Dx Cartridge, Enabling Cost-Effective Field Applications

DELRAY BEACH, Fla., Aug. 26, 2015 (GLOBE NEWSWIRE) - PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today that it successfully achieved a new milestone in the development of its Firefly Dx PCR (polymerase chain reaction) prototype pathogen detection system (“prototype system”) with the production of the Company’s first article, molded PCR chips for the Firefly Dx cartridge.

The completion of injection-molded PCR chips represents the next stage of product maturity for the Firefly Dx prototype system. This advancement will enable the Company to produce large quantities of PCR chips at a lower cost, thereby enabling higher throughput of testing data and cost-effective field applications. PositiveID will now be able to incorporate and optimize additional assays on its Firefly Dx cartridge with a disposable PCR chip.

Continue Reading

Top PerformerYesterday's Top Performer

Pazoo Inc. (Pink Sheets: PZOO)

End of Day:

Price: 0.0057

Change (%): + 0.0012 (26.67)

Volume: 9,870,490
PZOO Chart

Pazoo, Inc. Will Hold Conference Call Wednesday August 26, 2015

WHIPPANY, N.J., Aug. 20, 2015 /PRNewswire/ - Pazoo, Inc. (OTC Pinks: PZOO) (German WKN#: A1J3DK), is pleased to report that Pazoo will hold a conference call next Wednesday, August 26, 2015, from 12:00 noon to 2:00 p.m. eastern time. Pazoo CEO, David Cunic, will be answering questions sent to the company in advance by those wishing to learn more about what is transpiring with the company. Due to time constraints, we may not be able to answer all questions submitted. Also we may be limited by the nature of the information sought. Pazoo will not disclose any non-public information, nor will it disclose any information that is subject to any confidentiality agreement or any information the disclosure of which would violate any agreement, law, rule or regulation to which the Pazoo subject. We will likely be answering questions regarding Pazoo’s increasing footprint in the marijuana industry. No information provided on the conference call should be considered legal advice regarding any laws or regulations Pazoo is required to comply with in this arena. Any participant on the call should seek independent legal counsel regarding any concerns they may have in this regard.

Listen to Conference Call

SmallCapVoice Clients' News

Company: BioCorRx Inc. (OTCQB: BICX)

BioCorRx, Inc. Announces Start Fresh Program(r) availability at Irvine, CA Wellness Center

Los Angeles, Aug. 27, 2015 (GLOBE NEWSWIRE) - BioCorRx, Inc. (BICX), developer of the Start Fresh Program, a Medication-Assisted Treatment (MAT) program, announces distribution to Next Advanced Medicine in Irvine, CA. This opening is in line with the company’s continued focus on distributing its addiction treatment program to wellness centers through a partnership with Myriad Medical Marketing (MMM). Next Advanced Medicine is located at 4980 Barranca Pkwy #200, Irvine, CA 92604 and is the second center to partner with BioCorRx under the distribution model. The center expects to begin seeing patients in early September. “The expansion into another wellness center, especially this particular one in Irvine, is very exciting as it’s an exceptional center with an excellent team in place. We look forward to working with the staff at Next Advanced Medicine.” stated COO & interim CEO, Brady Granier.

“This center is in an ideal location for Orange County and has a large existing patient base, many whom have family members or who themselves can benefit from our program. We believe that implementing our program in this setting is beneficial to the patients and their families, as they can receive holistic care in the same location where they are receiving treatment on a private, out-patient basis for their addiction to alcohol or opioids,” said Granier.

Continue Reading

Company: Medical Marijuana Inc. (Pink Sheets: MJNA)

Photo Release -- Medical Marijuana, Inc.'s Kannaway Announces Expansion of Executive Leadership Team

Proven Global Network Marketing Senior Executive and Business Builder, Brad Tayles, Joins Kannaway's Hemp Revolution

SAN DIEGO, Aug. 27, 2015 (GLOBE NEWSWIRE) - Medical Marijuana, Inc.’s (OTC Pink:MJNA) Kannaway is proud to announce the addition of Mr. Bradley (Brad) J. Tayles as Vice President of Operations. The company focuses on hemp history in the U.S., consumer education of the plant’s more than 50,000 innovative uses, and the opportunity to take part in a “hemp revolution” that is returning hemp to consumers’ daily lives with unique hemp cannabidiol (CBD) oil products.

“We are very fortunate that Brad Tayles joined the Kannaway organization and welcome him to our team,” states Jeff Rogers, Chief Executive Officer of Kannaway. “His experience in the network marketing industry is an invaluable asset to the corporate team and to the ‘Kannaway Nation’. Having the ability to attract industry icons like Brad Tayles is the reason why we feel Kannaway has become a legacy company in the MLM industry.”

Continue Reading

Other Small Cap News

Company: Wizard World (OTCBB: WIZD)

‘X-Files’ Star David Duchovny Added to Wizard World Comic Con Pittsburgh on Saturday, September 12

‘Fox Mulder’ on Iconic Sci-Fi Series, ‘Hank Moody’ On ‘Californication’ Joins Somerhalder, Shatner, Staite at David L. Lawrence Convention Center in First Wizard World Comic Con Appearance

PITTSBURGH--(BUSINESS WIRE)--David Duchovny, best known for portraying such iconic characters as “Fox Mulder” on “The X Files” and “Hank Moody” on “Californication,” will make his first-ever Wizard World appearance at Wizard World Comic Con Pittsburgh on Saturday, September 12 at the David L. Lawrence Convention Center. The two-time Golden Globe winner is currently starring in the NBC TV series “Aquarius” and earlier this year, Duchovny released his first novel, Holy Cow, which landed on The New York Times’ Bestseller List.

Continue Reading

Company: mCig, Inc. (OTCQB: MCIG)

mCig Updates Shareholders on Status of 10K Filing

BEVERLY HILLS, CA--(Marketwired - Aug 27, 2015) - mCig, Inc. (OTCQB: MCIG), a leading distributor of innovative products, technologies and services for the global medical and legal recreational cannabis industry, announces that as a result of a change in auditors, the annual report on Form 10-K was delayed. mCig expects to file its Form 10-K shortly with an audit report from its new independent registered public accounting firm SADLER, GIBB & ASSOCIATES, LLC.

While we appreciate shareholders' patience with regards to MCIG soon to be released filing, we felt it necessary to provide an update in the matter. New accounting was only one of many initiatives implemented by mCig to improve compliance and visibility. These measures had to be put in place as new product lines and increasing revenue streams will have an impact in how we report moving forward. The implementation of new fulfillment and distribution revenue verticals coupled with our new accounting software will make future reporting more accurate and timely.

Continue Reading

Company: Aequus Pharmaceuticals Inc. (OTCQB: AQSZF) (TSX-V: AQS)

Aequus Pharmaceuticals Announces Trading on OTCQB

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 27, 2015) - Aequus Pharmaceuticals Inc. (TSX VENTURE:AQS) (OTCQB:AQSZF) ("Aequus" or "the Company"), announced today its stock is now trading on the OTCQB® Venture Market in the United States under the symbol "AQSZF."

"Admission to the OTCQB market is part of a long-term strategy to introduce the company to a broader international audience," said Doug Janzen, Chairman and CEO of Aequus. "This provides us with a trading platform for current and future American investors as well as a means of increasing our international visibility."

Continue Reading

Company: Stellar Biotechnologies, Inc. (OTCQB: SBOTF) (TSX-V: KLH)

Stellar Biotechnologies Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market

PORT HUENEME, CA--(Marketwired - Aug 28, 2015) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), today announced that, subject to regulatory approval, the Company will proceed with a consolidation of its issued and outstanding common shares (the "Shares") on the basis of one (1) post-consolidated common Share for every ten (10) pre-consolidated Shares (the "Reverse Split").

The Company's Board of Directors approved the Reverse Split on August 26, 2015, in preparation for its planned uplisting to the NASDAQ Capital Market ("NASDAQ"). The Company has filed an application to have its common stock approved for trading on NASDAQ and the Reverse Split is intended to fulfill one of the quantitative requirements for listing. However, there can be no assurance that NASDAQ will approve the Company's application or, if the Company's stock is uplisted, that the Company will be able to maintain minimum listing requirements.

Continue Reading

Market News

By Tanya Agrawal: Reuters

Wall Street opens lower as investors wary after hectic week

Wall Street opened lower on Friday, suggesting investors were wary of taking big positions into the weekend after days of tumultuous trading that featured both the market's worst day in four years and biggest two-day gain since the financial crisis.

Even so, the three major U.S. indexes looked set to end the week higher after a brutal selloff early in the week sparked by worries about the health of the Chinese economy.

"A lot of investors are looking for markets to calm down and are rebalancing their portfolios before going into the weekend," said Jeff Carbone, co-founder and managing partner of Cornerstone Financial Partners.

Continue Reading

By Engen Tham and Shu Zhang:

China banks warn of rising bad loans and falling margins as economy slows

China's largest banks warned of a tough year after posting their weakest half-yearly profit growth in at least six years as a slowing economy forces the lenders to make even more provisions for soured loans and squeezes interest income.

State-owned Industrial and Commercial Bank of China, China's largest bank by assets, and peers Bank of China (BOC), Agricultural Bank of China and Bank of Communications this week reported another spike in bad loans in the first half and net profits that grew at most by 1.5 percent, a far cry from the double- digit growth banks enjoyed after the 2008 financial crisis.

With China's economy set to grow at its weakest pace in a quarter of a century this year, the lenders said they were bracing themselves for even more bad loans as industries ranging from steel to petrochemicals and property struggle.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks